One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients

Background It is unknown whether contemporary drug‐eluting stents have a similar safety profile in high bleeding risk patients treated with 1‐month dual antiplatelet therapy following percutaneous coronary interventions. Methods and Results We performed an interventional, prospective, multicenter, s...

Full description

Bibliographic Details
Main Authors:	Carlo A. Pivato, Bernhard Reimers, Luca Testa, Andrea Pacchioni, Carlo Briguori, Carmine Musto, Giovanni Esposito, Raffaele Piccolo, Luigi Lucisano, Leonardo De Luca, Federico Conrotto, Andrea De Marco, Anna Franzone, Patrizia Presbitero, Giuseppe Ferrante, Gerolama Condorelli, Valeria Paradies, Gennaro Sardella, Ciro Indolfi, Gianluigi Condorelli, Giulio G. Stefanini
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	bioresorbable polymer stent coronary artery disease high bleeding risk percutaneous coronary intervention short DAPT Synergy stent
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.023454

Similar Items

Bioresorbable scaffolds: current concepts and future technology
by: Debabrata Dash, et al.
Published: (2022-08-01)

Bioresorbable Coronary Scaffolds: Current State of Evidence
by: Sunny Goel, et al.
Published: (2017-10-01)

Nanoparticles-reinforced poly-l-lactic acid composite materials as bioresorbable scaffold candidates for coronary stents: insights from mechanical and finite element analysis
by: Toong, Daniel Wee Yee, et al.
Published: (2022)

Mechanical behavior of polymer-based vs. metallic-based bioresorbable stents
by: Ang, Hui Ying, et al.
Published: (2019)

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial
by: Zacharenia Kallinikou, et al.
Published: (2016-01-01)

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01)

Highlighting Hemodynamic Risks for Bioresorbable Stents in Coronary Arteries
by: Marcus S. Elliott, et al.
Published: (2023-08-01)

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
by: T. M. Hommels, et al.
Published: (2020-10-01)

Bioresorbable scaffolds: History and current knowledge
by: Min Ma, et al.
Published: (2016-01-01)

Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
by: Kathrin Pahmeier, et al.
Published: (2022-08-01)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
by: Beytullah Cakal, et al.
Published: (2020-12-01)

Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations
by: Katharina Schochlow, et al.
Published: (2021-04-01)

One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
by: Nabijon P. Yuldashev, et al.
Published: (2018-03-01)

Long-Term Outcomes After Implantation of Magnesium-Based Bioresorbable Scaffolds—Insights From an All-Comer Registry
by: Matthias Bossard, et al.
Published: (2022-04-01)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
by: Piotr Desperak, et al.
Published: (2020-04-01)

Moving research direction in the field of metallic bioresorbable stents-A mini-review
by: Xiehui Chen, et al.
Published: (2023-06-01)

Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs
by: Alberto Polimeni, et al.
Published: (2017-06-01)

The Future of Cardiovascular Stents: Bioresorbable and Integrated Biosensor Technology
by: Daniel Hoare, et al.
Published: (2019-10-01)

Effect of implantation technique on outcomes in patients receiving bioresorbable scaffolds in various clinical scenarios
by: Luis Ortega-Paz, et al.
Published: (2019-05-01)

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
by: Surender Deora, et al.
Published: (2014-07-01)

Recurrent atherosclerosis complications as a mechanism for stent failure
by: Ioannis Andreou, et al.
Published: (2020-01-01)

The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy
by: Francesco Nappi, et al.
Published: (2021-01-01)

The Development of Coronary Artery Stents: From Bare-Metal to Bio-Resorbable Types
by: Ming-Yun Ho, et al.
Published: (2016-07-01)

Feasibility, safety, and efficacy of iron bioresorbable scaffold in neonates with duct-dependent pulmonary circulation
by: Marhisham Che Mood, et al.
Published: (2022-01-01)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
by: Brian Forrestal, et al.
Published: (2020-04-01)

COMPARATIVE ANALYSIS OF THE INFLAMMATORY RESPOND OF THE VASCULAR WALL AFTER IMPLANTATION OF BIORESORBABLE SCAFFOLDS AND EVEROLIMUS COVERED STENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: N. A. Musikhina, et al.
Published: (2019-02-01)

Degradation modeling of poly-l-lactide acid (PLLA) bioresorbable vascular scaffold within a coronary artery
by: Lin Shengmao, et al.
Published: (2020-12-01)

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
by: T. M. Hommels, et al.
Published: (2019-03-01)

Analysis of trends and prospects regarding stents for human blood vessels
by: Jeong Hee Lee, et al.
Published: (2018-03-01)

Experimental Tests, FEM Constitutive Modeling and Validation of PLGA Bioresorbable Polymer for Stent Applications
by: Jakub Bukala, et al.
Published: (2020-04-01)

Advances in Fabrication Technologies for the Development of Next-Generation Cardiovascular Stents
by: Ankita Das, et al.
Published: (2023-11-01)

Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease
by: BHARGAV DAVE
Published: (2016-10-01)

Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery
by: Jian-Feng Zheng, et al.
Published: (2022-11-01)

The Development of Design and Manufacture Techniques for Bioresorbable Coronary Artery Stents
by: Liang Wang, et al.
Published: (2021-08-01)

Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention
by: Rym El Khoury, MD, et al.
Published: (2023-01-01)

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds
by: Remzi Anadol, et al.
Published: (2018-05-01)

Comparison of diagnostic accuracy of immediate angiography derived residual quantitative flow ratio after bioresorbable scaffold and drug eluting stent implantation
by: Zhengwei Li, et al.
Published: (2022-02-01)

PERCUTANEOUS CORONARY INTERVENTIONS – CURRENT STATE OF DEVELOPMENT: STENTS EVOLUTION
by: Chernyak A. A., et al.
Published: (2020-11-01)

Bioresorbable vascular scaffold (BVS) for the treatment of native coronary artery stenosis: one year
by: Hazem Khamis, et al.
Published: (2016-12-01)

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years)
by: Adrian Włodarczak, et al.
Published: (2024-03-01)